Expediting treatment in patients with stage 1 melanoma is associated with improved outcomes, however physicians must work toward finding a safe window to treat these patients following diagnosis, according to study results published in the Journal of the American Academy of Dermatology.

Although accelerating melanoma treatment, in particular surgery, is a priority for most patients, such urgency may exceed surgeon or hospital availability. Therefore, dermatologists must first consider the biology of a patient’s tumor.